ALYSSA HOUSEHOLDER: Open Payments
NPI 1972209666 · CLEARWATER, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,850 in 74 payments from 12 companies in 2025. Trend: 2023 $735 · 2024 $1,016 · 2025 $1,850
Food & beverage: $1,850
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 19 | $394 |
| Takeda Pharmaceuticals U.S.A., Inc. | 12 | $280 |
| Madrigal Pharmaceuticals | 8 | $278 |
| Janssen Biotech, Inc. | 10 | $270 |
| PFIZER INC. | 8 | $176 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 5 | $121 |
| Gilead Sciences, Inc. | 4 | $111 |
| Aimmune Therapeutics, Inc. | 2 | $62 |
| Regeneron Healthcare Solutions, Inc. | 2 | $53 |
| QOL Medical, LLC | 2 | $48 |
Products named: REZDIFFRA, TREMFYA, ENTYVIO, XELJANZ, XIFAXAN, SKYRIZI, Linzess, RINVOQ.
Industry payments across FL — which companies pay providers there.
